Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target

Xiaofeng Duan, Stephen Iwanowycz, Soo Ngoi, Megan Hill, Qiang Zhao, Bei Liu

Open source

DOI
10.3389/fonc.2021.629846
Published
2021-04-09
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2021.629846,
  title = {Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target},
  author = {Xiaofeng Duan and Stephen Iwanowycz and Soo Ngoi and Megan Hill and Qiang Zhao and Bei Liu},
  year = {2021},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2021.629846},
  url = {https://doi.org/10.3389/fonc.2021.629846}
}

RIS

TY  - JOUR
TI  - Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target
AU  - Xiaofeng Duan
AU  - Stephen Iwanowycz
AU  - Soo Ngoi
AU  - Megan Hill
AU  - Qiang Zhao
AU  - Bei Liu
PY  - 2021
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2021.629846
UR  - https://doi.org/10.3389/fonc.2021.629846
ER  - 

APA

Duan, X., Iwanowycz, S., Ngoi, S., Hill, M., Zhao, Q., & Liu, B. (2021). Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target. Frontiers in Oncology. https://doi.org/10.3389/fonc.2021.629846

Source records